Development and validation of a UPLC–MS/MS method for the novel folate-targeted small molecule drug conjugate EC1456 and its metabolites in tumor homogenates from mice
A SMDC is delivered to GCPII, an important cancer target. The payload is released by enzymes overexpressed in cancer cell lines. The SMDC relies on GCPII expression for efficacy.